Consumer Products

We work with major consumer products manufacturers to help them predict the predict hepatotoxic risks of their compounds and model metabolism and hepatic clearance.

We have demonstrated that our hepatic in vitro models are superior at predicting clinical outcomes compared to conventional in vitro models and in vivo models. Our hepatic in vitro models incorporate uptake and efflux function making them more physiologically-relevant.

Using our Human Dynamic Multiple Organ Plate technology we are able to evaluate the movement of a compound from one organ to another and predict the pharmacokinetic effects of the compound.